Finance, Business Development and Planning Analyst

Finance, Business Development and Planning Analyst

• 12.06.2014

Philip Morris representative office in Moldova is looking for a person who will contribute to company business growth and provide solid support in strategy development and day-to-day activities.

We expect you to:

• Establish the process or follow already developed procedures for preparation various results, reports, analysis and budgets according to the needs and instructions and within the required time;
• Review and validate the data received to ensure its accuracy and suitability as a basis for reporting/planning;
• Propose improvements of the reporting/planning systems, methods of work and analysis methods and contribute to ensuring that they are continuously adapted to the business requirements;
• Support the department in identifying and analyzing business problems and achieving optimal solutions by providing management with the highest quality data and analysis of identified business developments and opportunities;
• Support business development projects in cooperation with other departments.

Requirements:

• University graduated: Economics, Business Administration, Mathematics
• Experience in Finance (2+ years)
• Good PC skills (MS Word, MS Excel, MS Power Point)
• Fluent in Romanian, Russian and English

Only shortlisted applicants will be contacted for an interview.

Please submit your CV to Recruitment.Moldova2@pmi.com with email title “Finance, Business Development and Planning Analyst”.
 

Philip Morris Sales & Marketing

Philip Morris Sales & Marketing was established in the Republic of Moldova in 1996. It is one of the largest tobacco companies from the Republic of Moldova, striving to be a responsible employer, a major contributor to the state budget and a promoter of the sustainability principles. Philip Morris Sales & Marketing is the affiliate of Philip Morris International, a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies.